1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Stem Cell 1.2.3 Non-Stem Cell 1.3 Market by Application 1.3.1 Global Cellular Therapy (CT) Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cellular Therapy (CT) Market Perspective (2017-2028) 2.2 Cellular Therapy (CT) Growth Trends by Region 2.2.1 Cellular Therapy (CT) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2017-2022) 2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2023-2028) 2.3 Cellular Therapy (CT) Market Dynamics 2.3.1 Cellular Therapy (CT) Industry Trends 2.3.2 Cellular Therapy (CT) Market Drivers 2.3.3 Cellular Therapy (CT) Market Challenges 2.3.4 Cellular Therapy (CT) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cellular Therapy (CT) Players by Revenue 3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2017-2022) 3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2017-2022) 3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue 3.4 Global Cellular Therapy (CT) Market Concentration Ratio 3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2021 3.5 Cellular Therapy (CT) Key Players Head office and Area Served 3.6 Key Players Cellular Therapy (CT) Product Solution and Service 3.7 Date of Enter into Cellular Therapy (CT) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cellular Therapy (CT) Breakdown Data by Type 4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2017-2022) 4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2023-2028) 5 Cellular Therapy (CT) Breakdown Data by Application 5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2017-2022) 5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cellular Therapy (CT) Market Size (2017-2028) 6.2 North America Cellular Therapy (CT) Market Size by Country (2017-2022) 6.3 North America Cellular Therapy (CT) Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Cellular Therapy (CT) Market Size (2017-2028) 7.2 Europe Cellular Therapy (CT) Market Size by Country (2017-2022) 7.3 Europe Cellular Therapy (CT) Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2017-2028) 8.2 Asia-Pacific Cellular Therapy (CT) Market Size by Country (2017-2022) 8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Cellular Therapy (CT) Market Size (2017-2028) 9.2 Latin America Cellular Therapy (CT) Market Size by Country (2017-2022) 9.3 Latin America Cellular Therapy (CT) Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2017-2028) 10.2 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2017-2022) 10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Gilead Sciences 11.1.1 Gilead Sciences Company Detail 11.1.2 Gilead Sciences Business Overview 11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction 11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2017-2022) 11.1.5 Gilead Sciences Recent Development 11.2 Novartis 11.2.1 Novartis Company Detail 11.2.2 Novartis Business Overview 11.2.3 Novartis Cellular Therapy (CT) Introduction 11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2017-2022) 11.2.5 Novartis Recent Development 11.3 Osiris 11.3.1 Osiris Company Detail 11.3.2 Osiris Business Overview 11.3.3 Osiris Cellular Therapy (CT) Introduction 11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2017-2022) 11.3.5 Osiris Recent Development 11.4 Vericel Corporation 11.4.1 Vericel Corporation Company Detail 11.4.2 Vericel Corporation Business Overview 11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction 11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2017-2022) 11.4.5 Vericel Corporation Recent Development 11.5 Vcanbio 11.5.1 Vcanbio Company Detail 11.5.2 Vcanbio Business Overview 11.5.3 Vcanbio Cellular Therapy (CT) Introduction 11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2017-2022) 11.5.5 Vcanbio Recent Development 11.6 Fujifilm Cellular Dynamics 11.6.1 Fujifilm Cellular Dynamics Company Detail 11.6.2 Fujifilm Cellular Dynamics Business Overview 11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction 11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2017-2022) 11.6.5 Fujifilm Cellular Dynamics Recent Development 11.7 JCR Pharmaceuticals 11.7.1 JCR Pharmaceuticals Company Detail 11.7.2 JCR Pharmaceuticals Business Overview 11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction 11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2017-2022) 11.7.5 JCR Pharmaceuticals Recent Development 11.8 Beike Biotechnology 11.8.1 Beike Biotechnology Company Detail 11.8.2 Beike Biotechnology Business Overview 11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction 11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2017-2022) 11.8.5 Beike Biotechnology Recent Development 11.9 Golden Meditech 11.9.1 Golden Meditech Company Detail 11.9.2 Golden Meditech Business Overview 11.9.3 Golden Meditech Cellular Therapy (CT) Introduction 11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2017-2022) 11.9.5 Golden Meditech Recent Development 11.10 Guanhao Biotech 11.10.1 Guanhao Biotech Company Detail 11.10.2 Guanhao Biotech Business Overview 11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction 11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2017-2022) 11.10.5 Guanhao Biotech Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cellular Therapy (CT) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Stem Cell Table 3. Key Players of Non-Stem Cell Table 4. Global Cellular Therapy (CT) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Cellular Therapy (CT) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Cellular Therapy (CT) Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Cellular Therapy (CT) Market Share by Region (2017-2022) Table 8. Global Cellular Therapy (CT) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Cellular Therapy (CT) Market Share by Region (2023-2028) Table 10. Cellular Therapy (CT) Market Trends Table 11. Cellular Therapy (CT) Market Drivers Table 12. Cellular Therapy (CT) Market Challenges Table 13. Cellular Therapy (CT) Market Restraints Table 14. Global Cellular Therapy (CT) Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Cellular Therapy (CT) Market Share by Players (2017-2022) Table 16. Global Top Cellular Therapy (CT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Therapy (CT) as of 2021) Table 17. Ranking of Global Top Cellular Therapy (CT) Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Cellular Therapy (CT) Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cellular Therapy (CT) Product Solution and Service Table 21. Date of Enter into Cellular Therapy (CT) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cellular Therapy (CT) Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Cellular Therapy (CT) Revenue Market Share by Type (2017-2022) Table 25. Global Cellular Therapy (CT) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Cellular Therapy (CT) Revenue Market Share by Type (2023-2028) Table 27. Global Cellular Therapy (CT) Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Cellular Therapy (CT) Revenue Market Share by Application (2017-2022) Table 29. Global Cellular Therapy (CT) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Cellular Therapy (CT) Revenue Market Share by Application (2023-2028) Table 31. North America Cellular Therapy (CT) Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Cellular Therapy (CT) Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Cellular Therapy (CT) Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Cellular Therapy (CT) Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Cellular Therapy (CT) Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Cellular Therapy (CT) Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Cellular Therapy (CT) Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Cellular Therapy (CT) Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Cellular Therapy (CT) Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Cellular Therapy (CT) Market Size by Country (2023-2028) & (US$ Million) Table 41. Gilead Sciences Company Detail Table 42. Gilead Sciences Business Overview Table 43. Gilead Sciences Cellular Therapy (CT) Product Table 44. Gilead Sciences Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 45. Gilead Sciences Recent Development Table 46. Novartis Company Detail Table 47. Novartis Business Overview Table 48. Novartis Cellular Therapy (CT) Product Table 49. Novartis Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 50. Novartis Recent Development Table 51. Osiris Company Detail Table 52. Osiris Business Overview Table 53. Osiris Cellular Therapy (CT) Product Table 54. Osiris Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 55. Osiris Recent Development Table 56. Vericel Corporation Company Detail Table 57. Vericel Corporation Business Overview Table 58. Vericel Corporation Cellular Therapy (CT) Product Table 59. Vericel Corporation Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 60. Vericel Corporation Recent Development Table 61. Vcanbio Company Detail Table 62. Vcanbio Business Overview Table 63. Vcanbio Cellular Therapy (CT) Product Table 64. Vcanbio Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 65. Vcanbio Recent Development Table 66. Fujifilm Cellular Dynamics Company Detail Table 67. Fujifilm Cellular Dynamics Business Overview Table 68. Fujifilm Cellular Dynamics Cellular Therapy (CT) Product Table 69. Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 70. Fujifilm Cellular Dynamics Recent Development Table 71. JCR Pharmaceuticals Company Detail Table 72. JCR Pharmaceuticals Business Overview Table 73. JCR Pharmaceuticals Cellular Therapy (CT) Product Table 74. JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 75. JCR Pharmaceuticals Recent Development Table 76. Beike Biotechnology Company Detail Table 77. Beike Biotechnology Business Overview Table 78. Beike Biotechnology Cellular Therapy (CT) Product Table 79. Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 80. Beike Biotechnology Recent Development Table 81. Golden Meditech Company Detail Table 82. Golden Meditech Business Overview Table 83. Golden Meditech Cellular Therapy (CT) Product Table 84. Golden Meditech Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 85. Golden Meditech Recent Development Table 86. Guanhao Biotech Company Detail Table 87. Guanhao Biotech Business Overview Table 88. Guanhao Biotech Cellular Therapy (CT) Product Table 89. Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2017-2022) & (US$ Million) Table 90. Guanhao Biotech Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Cellular Therapy (CT) Market Share by Type: 2021 VS 2028 Figure 2. Stem Cell Features Figure 3. Non-Stem Cell Features Figure 4. Global Cellular Therapy (CT) Market Share by Application in 2021 & 2028 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Cellular Therapy (CT) Report Years Considered Figure 9. Global Cellular Therapy (CT) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Cellular Therapy (CT) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Cellular Therapy (CT) Market Share by Region: 2021 VS 2028 Figure 12. Global Cellular Therapy (CT) Market Share by Players in 2021 Figure 13. Global Top Cellular Therapy (CT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Therapy (CT) as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Cellular Therapy (CT) Revenue in 2021 Figure 15. North America Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Cellular Therapy (CT) Market Share by Country (2017-2028) Figure 17. United States Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Cellular Therapy (CT) Market Share by Country (2017-2028) Figure 21. Germany Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Cellular Therapy (CT) Market Share by Region (2017-2028) Figure 29. China Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Cellular Therapy (CT) Market Share by Country (2017-2028) Figure 37. Mexico Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Cellular Therapy (CT) Market Share by Country (2017-2028) Figure 41. Turkey Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Cellular Therapy (CT) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Gilead Sciences Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 44. Novartis Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 45. Osiris Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 46. Vericel Corporation Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 47. Vcanbio Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 48. Fujifilm Cellular Dynamics Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 49. JCR Pharmaceuticals Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 50. Beike Biotechnology Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 51. Golden Meditech Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 52. Guanhao Biotech Revenue Growth Rate in Cellular Therapy (CT) Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Gilead Sciences Novartis Osiris Vericel Corporation Vcanbio Fujifilm Cellular Dynamics JCR Pharmaceuticals Beike Biotechnology Golden Meditech Guanhao Biotech